Loading organizations...
Based in Ann Arbor, Michigan, Fifth Eye develops FDA-cleared medical device software that analyzes continuous electrocardiogram signals to predict and monitor hemodynamic instability in post-operative hospital patients. The company's primary commercial offering, known as the AHI System, provides healthcare professionals with continuous surveillance data, real-time patient status updates, and early warnings of clinical deterioration. Prior to its exit, the startup raised a total of $21.51 million in venture funding, highlighted by an $11.5 million Series A financing round led by Arboretum Ventures and Cultivation Capital. Originally built to commercialize predictive analytics technology licensed directly from the University of Michigan, the enterprise was ultimately acquired by healthcare software provider AirStrip in June 2025. Fifth Eye was officially founded in 2017 by the core executive team of Jen Baird, Mark Salamango, Ashwin Belle, and Bryce Benson.
Fifth Eye has raised $11.5M across 1 funding round.
Fifth Eye has raised $11.5M in total across 1 funding round.
Fifth Eye has raised $11.5M across 1 funding round. Most recently, it raised $11.5M Series A in April 2019.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Apr 1, 2019 | $11.5M Series A | Thomas Shehab, MD, MMM, William Schmidt | Invest Michigan, Mints | Announced |
Fifth Eye has raised $11.5M in total across 1 funding round.
Fifth Eye's investors include Thomas Shehab, MD, MMM, William Schmidt, Invest Michigan, MINTS.
